Evidence map›Paper›PMID 33092630›Full record

ArticleGenome medicine2020

Wnt-regulated lncRNA discovery enhanced by in vivo identification and CRISPRi functional validation.

Shiyang Liu, Nathan Harmston, Trudy Lee Glaser, Yunka Wong, Zheng Zhong, Babita Madan, David M Virshup, Enrico Petretto

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Shiyang LiuProgram in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
Nathan HarmstonScience Division, Yale-NUS College, Singapore, Singapore.
Trudy Lee GlaserProgram in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
Yunka WongProgram in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
Zheng ZhongProgram in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
Babita MadanProgram in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
David M VirshupProgram in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore. david.virshup@duke-nus.edu.sg.
Enrico PetrettoProgram in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, Singapore. enrico.petretto@duke-nus.edu.sg.ORCID 0000-0003-2163-5921
Duke-NUS Medical School · SGDuke University · USYale-NUS College · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWnt signaling is an evolutionarily conserved developmental pathway that is frequently hyperactivated in cancer. While multiple protein-coding genes regulated by Wnt signaling are known, the functional lncRNAs regulated by Wnt signaling have not been systematically characterized.

methodsWe comprehensively mapped Wnt-regulated lncRNAs from an orthotopic Wnt-addicted pancreatic cancer model and examined the response of lncRNAs to Wnt inhibition between in vivo and in vitro cancer models. We further annotated and characterized these Wnt-regulated lncRNAs using existing genomic classifications (using data from FANTOM5) in the context of Wnt signaling and inferred their role in cancer pathogenesis (using GWAS and expression data from the TCGA). To functionally validate Wnt-regulated lncRNAs, we performed CRISPRi screens to assess their role in cancer cell proliferation both in vivo and in vitro.

resultsWe identified 3633 lncRNAs, of which 1503 were regulated by Wnt signaling in an orthotopic Wnt-addicted pancreatic cancer model. These lncRNAs were much more sensitive to changes in Wnt signaling in xenografts than in cultured cells. Our analysis suggested that Wnt signaling inhibition could influence the co-expression relationship of Wnt-regulated lncRNAs and their eQTL-linked protein-coding genes. Wnt-regulated lncRNAs were also implicated in specific gene networks involved in distinct biological processes that contribute to the pathogenesis of cancers. Consistent with previous genome-wide lncRNA CRISPRi screens, around 1% (13/1503) of the Wnt-regulated lncRNAs were found to modify cancer cell growth in vitro. This included CCAT1 and LINC00263, previously reported to regulate cancer growth. Using an in vivo CRISPRi screen, we doubled the discovery rate, identifying twice as many Wnt-regulated lncRNAs (25/1503) that had a functional effect on cancer cell growth.

conclusionsOur study demonstrates the value of studying lncRNA functions in vivo, provides a valuable resource of lncRNAs regulated by Wnt signaling, and establishes a framework for systematic discovery of functional lncRNAs.

Indexed as

Gene Expression ProfilingGene Expression RegulationRNA, Long NoncodingAnimalsClustered Regularly Interspaced Short Palindromic RepeatsComputational BiologyGene EditingGene Expression Regulation, NeoplasticGene Knockdown TechniquesGene Regulatory NetworksHeterograftsHumansMiceNeoplasmsOpen Reading FramesQuantitative Trait LociRNA, Guide, CRISPR-Cas SystemsRNA, Long NoncodingWnt ProteinsCancerCRISPRi screenFunctional lncRNAsWnt signaling

Identifiers

PMID33092630
PMCPMC7580003
OpenAlexW3094576035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.